University Health Network, Toronto, ON, Canada.
Sinai Health System, Toronto, ON, Canada.
J Hosp Med. 2018 Mar 1;13(3):152-157. doi: 10.12788/jhm.2857. Epub 2017 Oct 4.
Although medication reconciliation (Med Rec) has demonstrated a reduction in potential adverse drug events, its effect on hospital readmissions remains inconclusive.
To evaluate the impact of an interprofessional Med Rec bundle from admission to discharge on patient emergency department visits and hospital readmissions (hospital visits).
The design was a retrospective, cohort study. Patients discharged from general internal medicine over a 57-month interval were identified through administrative databases. Patients who received an enhanced, Gold level, Med Rec bundle (including both admission Med Rec and interprofessional pharmacist-prescriber collaboration on discharge Med Rec) were assigned to the intervention group. Patients who received partial Med Rec services, Silver and Bronze level, comprised the control group. The primary outcome was hospital visits within 30 days of discharge.
Over a 57-month period, 9931 unique patient visits (n = 8678 patients) met the study criteria. The main analysis did not detect a difference in 30-day hospital visits between the intervention (Gold level bundle) and control (21.25% vs 19.26%; adjusted odds ratio, 1.06; 95% confidence interval [CI], 0.95-1.19). Propensity score adjustment also did not detect an effect (16.7% vs18.9%; relative risk of readmission, 0.88; 95% CI, 0.59-1.32).
A long-term, observational evaluation of interprofessional Med Rec did not detect a difference in 30- day postdischarge patient hospital visits between patients who received enhanced versus partial Med Rec patient care bundles. In future prospective studies, researchers could focus on evaluating high-risk populations and specific elements of Med Rec services on avoidable, medication-related hospital admissions and postdischarge adverse drug events.
尽管药物重整(Med Rec)已证明可减少潜在的药物不良事件,但它对医院再入院的影响仍不确定。
评估从入院到出院的跨专业 Med Rec 包对患者急诊就诊和医院再入院(医院就诊)的影响。
设计为回顾性队列研究。通过管理数据库确定在 57 个月间隔内从普通内科出院的患者。接受增强的、金级 Med Rec 包(包括入院 Med Rec 和出院 Med Rec 上的跨专业药剂师-处方医生合作)的患者被分配到干预组。接受部分 Med Rec 服务(银级和铜级)的患者构成对照组。主要结局是出院后 30 天内的医院就诊。
在 57 个月期间,有 9931 个独特的患者就诊(n = 8678 例患者)符合研究标准。主要分析未发现干预组(金级包)和对照组(30 天内医院就诊率分别为 21.25%和 19.26%;调整后的优势比为 1.06;95%置信区间 [CI],0.95-1.19)之间 30 天内医院就诊率存在差异。倾向评分调整也未发现效果(16.7%和 18.9%;再入院的相对风险,0.88;95%CI,0.59-1.32)。
对跨专业 Med Rec 的长期观察性评估未发现接受增强型与部分 Med Rec 患者护理包的患者在出院后 30 天内的患者医院就诊率存在差异。在未来的前瞻性研究中,研究人员可以专注于评估高危人群和 Med Rec 服务的特定要素对可避免的、与药物相关的住院和出院后药物不良事件的影响。